These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 7372430)

  • 1. Hormonal effect of subcapsular orchiectomy versus total orchiectomy.
    Tacker JR; Coker JE; Hosty TA; Albers DD
    Invest Urol; 1980 May; 17(6):441-2. PubMed ID: 7372430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of subcapsular and total orchiectomy for treatment of metastatic prostate cancer.
    Zhang XZ; Donovan MP; Williams BT; Mohler JL
    Urology; 1996 Mar; 47(3):402-4. PubMed ID: 8633409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orchiectomy.
    Alfthan O
    Scand J Urol Nephrol Suppl; 1980; 55():117-20. PubMed ID: 6259721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma androgen levels after subcapsular orchiectomy or estrogen treatment for prostatic carcinoma.
    Vermeulen A; Schelfhout W; De Sy W
    Prostate; 1982; 3(2):115-21. PubMed ID: 6211662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subcapsular versus total orchiectomy in the treatment of advanced prostate cancer: a randomized trial.
    Roosen JU; Klarskov OP; Mogensen P
    Scand J Urol Nephrol; 2005; 39(6):464-7. PubMed ID: 16303721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Subcapsular orchiectomy using the ultrasonic surgical aspirator in patients with advanced prostatic cancer].
    Yasumoto R; Minami H; Yoshihara H; Maekawa T; Ameno Y; Hayashi S; Nishisaka N; Kishimoto T
    Hinyokika Kiyo; 1992 Dec; 38(12):1379-81. PubMed ID: 1288226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of orchiectomy and various doses of stilbestrol on plasma testosterone levels in patients with carcinoma of the prostate.
    Mackler MA; Liberti JP; Smith MJ; Prout GR
    Surg Forum; 1970; 21():540-1. PubMed ID: 5535268
    [No Abstract]   [Full Text] [Related]  

  • 8. [Subcapsular orchiectomy. Indications and psychological aspects].
    Auvray P; Wart F
    Acta Urol Belg; 1980 Jan; 48(1):117-22. PubMed ID: 7435346
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of orchiectomy and various doses of stilbestrol on plasma testosterone levels in patients with carcinoma of the prostate.
    Mackler MA; Liberti JP; Smith MJ; Koontz WW; Prout GR
    Invest Urol; 1972 Mar; 9(5):423-5. PubMed ID: 5016026
    [No Abstract]   [Full Text] [Related]  

  • 10. Re: Failure to achieve castrate levels of testosterone during luteinizing hormone releasing hormone agonist therapy: the case for monitoring serum testosterone and a treatment decision algorithm.
    Guess B; Scholz M
    J Urol; 2001 May; 165(5):1644-5. PubMed ID: 11345950
    [No Abstract]   [Full Text] [Related]  

  • 11. [Subalbugineal orchiectomy. Experimental evaluation of a technic].
    Verdú Tartajo F; Romero Maroto J; González Gancedo P; Boronat Tormo F; García González R; Romero Aguirre C
    Arch Esp Urol; 1983; 36(4):229-33. PubMed ID: 6651356
    [No Abstract]   [Full Text] [Related]  

  • 12. Redefining clinically significant castration levels in patients with prostate cancer receiving continuous androgen deprivation therapy.
    Morote J; Orsola A; Planas J; Trilla E; Raventós CX; Cecchini L; Catalán R
    J Urol; 2007 Oct; 178(4 Pt 1):1290-5. PubMed ID: 17698136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of testosterone and LH values in subcapsular vs total orchiectomy patients.
    Chapman JP
    Urology; 1987 Jul; 30(1):27-8. PubMed ID: 3603905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bilateral orchiectomy in patients with progressive advanced prostatic cancer.
    Denis L; Nowe P
    Acta Urol Belg; 1980 Jan; 48(1):113-6. PubMed ID: 7435345
    [No Abstract]   [Full Text] [Related]  

  • 15. Subcapsular orchidectomy for carcinoma of the prostate.
    Clark P; Houghton L
    Br J Urol; 1977 Oct; 49(5):419-25. PubMed ID: 588938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of zinc deficiency and testosterone supplementation on leptin levels in castrated rats and their relation with LH, FSH and testosterone.
    Ozturk A; Baltaci AK; Mogulkoc R; Oztekin E; Kul A
    Neuro Endocrinol Lett; 2005 Oct; 26(5):548-54. PubMed ID: 16264402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen and prostatic stroma.
    Niu YJ; Ma TX; Zhang J; Xu Y; Han RF; Sun G
    Asian J Androl; 2003 Mar; 5(1):19-26. PubMed ID: 12646998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testosterone and zinc supplementation in castrated rats: Effects on plasma leptin levels and relation with LH, FSH and testosterone.
    Baltaci AK; Mogulkoc R; Ozturk A
    Life Sci; 2006 Jan; 78(7):746-52. PubMed ID: 16150461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid suppression of plasma testosterone levels and tumor growth in the dunning rat model treated with degarelix, a new gonadotropin-releasing hormone antagonist.
    Princivalle M; Broqua P; White R; Meyer J; Mayer G; Elliott L; Bjarnason K; Haigh R; Yea C
    J Pharmacol Exp Ther; 2007 Mar; 320(3):1113-8. PubMed ID: 17179469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of castration on dehydroepiandrosterone-induced hepatocarcinogenesis in male rats.
    Rao MS; Kashireddy P
    Anticancer Res; 2002; 22(3):1409-11. PubMed ID: 12168817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.